Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine


Bornstein J., Roux S., Petersen L. K. , Huang L., Dobson S. R. , Pitisuttithum P., ...More

PEDIATRICS, vol.147, no.1, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 147 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.1542/peds.2019-4035
  • Title of Journal : PEDIATRICS

Abstract

BACKGROUND AND OBJECTIVES: Human papillomavirus (HPV) antibody responses to the 9-valent human papillomavirus (9vHPV) vaccine among girls and boys (aged 9-14 years) receiving 2-dose regimens (months 0, 6 or 0, 12) were noninferior to a 3-dose regimen (months 0, 2, 6) in young women (aged 16-26 years) 4 weeks after last vaccination in an international, randomized, open-label trial (NCT01984697). We assessed response durability through month 36.